Atherogenesis and Coronary Heart Disease

作者: Russell P. Tracy

DOI: 10.1002/0470862092.D1001

关键词:

摘要: There are two major pathways by which atherosclerosis progresses: excess lipids in blood, end up atherosclerotic plaque, and inflammatory forces. Much recent research has demonstrated the association of chronic low-level inflammation (microinflammation) with both diabetes cardiovascular disease. It appears that microinflammation is not only a result these diseases but also exhibits “positive feedback,” causing disease process to accelerate. This downward spiral slope modified genetic architecture environmental variables, may prove difficult interrupt or modify effectively, since involved represent pathophysiology normal homeostatic physiology. We currently have some medications do seem work this process, such as aspirin statins. The role environment clearly important, now emerging. need for more effective public health efforts education behavior modification, well economic political approaches arrest burgeoning global epidemic obesity. already know if lipid burden decreased, will decrease. If we can understand microinflammatory enough detail, learn how activities, be able decrease through mechanism well, affect development other old age. By attacking arms finally limit progressive atherosclerosis, possibly age well. Keywords: diabetes; insulin resistance; inflammation; hemostasis; fibrinolysis; atherosclerosis; cardiovascular

参考文章(78)
Charles T Esmon, Fletcher B Taylor, T Russell Snow, Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thrombosis and Haemostasis. ,vol. 66, pp. 160- 165 ,(1991) , 10.1055/S-0038-1646385
Irène Juhan-Vague, Marie-Christine Alessi, Pierre E. Morange, PAI-1, Obesity, and Insulin Resistance Humana Press. pp. 317- 332 ,(1999) , 10.1007/978-1-59259-716-1_17
Zhonghua Tang, Russell P. Tracy, Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment. Journal of Thrombosis and Thrombolysis. ,vol. 11, pp. 49- 81 ,(2001) , 10.1023/A:1008956327032
Augusto Di Castelnuovo, Roberto Marchioli, Maria Benedetta Donati, Licia Iacoviello, Francesco Burzotta, Francesco Zito, The 4G/5G Polymorphism of PAI-1 Promoter Gene and the Risk of Myocardial Infarction: A Meta-analysis Thrombosis and Haemostasis. ,vol. 80, pp. 1029- 1030 ,(1998) , 10.1055/S-0037-1615408
E. Wesley Ely, Gordon R. Bernard, Jean-Louis Vincent, Activated Protein C for Severe Sepsis New England Journal of Medicine. ,vol. 347, pp. 1035- 1036 ,(2002) , 10.1056/NEJM200209263471315
Aaron R. Folsom, Kenneth K. Wu, Wayne D. Rosamond, A. Richey Sharrett, Lloyd E. Chambless, Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. ,vol. 96, pp. 1102- 1108 ,(1997) , 10.1161/01.CIR.96.4.1102
Wolfgang Koenig, Malte Sund, Margit Fröhlich, Hans-Günther Fischer, Hannelore Löwel, Angela Döring, Winston L. Hutchinson, Mark B. Pepys, C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men Results From the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation. ,vol. 99, pp. 237- 242 ,(1999) , 10.1161/01.CIR.99.2.237
T.W. Meade, R. Chakrabarti, A.P. Haines, W.R.S. North, Yvonne Stirling, S.G. Thompson, Milica Brozović, HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY The Lancet. ,vol. 315, pp. 1050- 1054 ,(1980) , 10.1016/S0140-6736(80)91498-1
DORON ARONSON, MURRAY A. MITTLEMAN, ANDREW J. BURGER, Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. Journal of Cardiovascular Electrophysiology. ,vol. 12, pp. 294- 300 ,(2001) , 10.1046/J.1540-8167.2001.00294.X
E. L. E. M. Bollen, Statin therapy and the prevention of dementia. JAMA Neurology. ,vol. 58, pp. 1023- 1024 ,(2001) , 10.1001/ARCHNEUR.58.6.1023